Lara M Simpson
Overview
Explore the profile of Lara M Simpson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Juraschek S, Simpson L, Davis B, Shmerling R, Beach J, Ishak A, et al.
J Hypertens
. 2020 Jan;
38(5):954-960.
PMID: 31977576
Objectives: Gout is a common complication of blood pressure management and a frequently cited cause of medication nonadherence. Little trial evidence exists to inform antihypertensive selection with regard to gout...
12.
Ho C, Breslin M, Chowdhury E, Doust J, Reid C, Davis B, et al.
J Hypertens
. 2019 Oct;
38(3):519-526.
PMID: 31584517
Objectives: To investigate legacy effects at 14-year follow-up of all-cause and cardiovascular disease (CVD) mortality in 'treatment-naive' or 'previous treatment' groups based on blood pressure (BP)-lowering treatment status at baseline....
13.
Juraschek S, Simpson L, Davis B, Beach J, Ishak A, Mukamal K
Hypertension
. 2019 Sep;
74(4):1033-1040.
PMID: 31476905
Hypertension treatment has been implicated in falls, syncope, and orthostatic hypotension (OH), common events among older adults. Whether the choice of antihypertensive agent influences the risk of falls, syncope, and...
14.
Bowling C, Davis B, Luciano A, Simpson L, Sloane R, Pieper C, et al.
J Clin Hypertens (Greenwich)
. 2019 Mar;
21(4):451-459.
PMID: 30864748
Achieving blood pressure (BP) control is associated with lower cardiovascular disease (CVD) risk, but less is known about CVD risk associated with sustained BP control over time. This observational analysis...
15.
Haywood L, Davis B, Piller L, Simpson L, Ghosh A, Einhorn P, et al.
J Natl Med Assoc
. 2018 Aug;
110(4):343-351.
PMID: 30126559
Background And Aims: ALLHAT, a randomized, double-blind, active-controlled, multicenter clinical trial of high risk hypertensive participants, compared treatment with an ACE-inhibitor (lisinopril) or calcium channel blocker (amlodipine) with a diuretic...
16.
Dewland T, Soliman E, Yamal J, Davis B, Alonso A, Albert C, et al.
Circ Arrhythm Electrophysiol
. 2017 Dec;
10(12).
PMID: 29212812
Background: Although atrial fibrillation (AF) guidelines indicate that pharmacological blockade of the renin-angiotensin system may be considered for primary AF prevention in hypertensive patients, previous studies have yielded conflicting results....
17.
Haywood L, Davis B, Piller L, Cushman W, Cutler J, Ford C, et al.
J Natl Med Assoc
. 2017 Oct;
109(3):172-181.
PMID: 28987246
Aims: Limited information is available on long-term antihypertensive and lipid-lowering therapy effects on hypertensive patients with atrial fibrillation/flutter (AF/AFL) compared to those without. AF/AFL at baseline or during the Antihypertensive...
18.
Alvarez O, Nottage K, Simpson L, Wood J, Davis B, Fuh B, et al.
Am J Hematol
. 2017 Jul;
92(11):E637-E639.
PMID: 28741677
No abstract available.
19.
Bang C, Soliman E, Simpson L, Davis B, Devereux R, Okin P
Am J Hypertens
. 2017 Apr;
30(9):914-922.
PMID: 28430947
Background: Electrocardiographic (ECG) left ventricular hypertrophy (LVH) is a strong predictor of cardiovascular (CV) morbidity and mortality. However, the predictive value of ECG LVH in treated hypertensive patients remains unclear....
20.
Chen D, Davis B, Simpson L, Cushman W, Cutler J, Dobre M, et al.
Clin Nephrol
. 2016 Dec;
87 (2017)(1):11-20.
PMID: 27900942
Background/objectives: Chronic kidney disease (CKD) and cancer are both common in older patients; whether CKD increases risk for cancer is unclear. This study evaluated CKD as a risk factor for...